GURU.Markets stock price, segment price, and overall market index valuation
The company's share price HeartBeam Inc.
Shares of HeartBeam, a company developing a device for remotely diagnosing heart attacks, are a highly speculative bet. Their price is driven by news about the product's development and its path to FDA approval.
Share prices of companies in the market segment - Heart
HeartBeam develops personal heart monitoring technology that allows patients to perform diagnostic ECGs at home. We've categorized it under "Heart." The chart below shows how investors value companies operating in the telemedicine and remote diagnostics sector.
Broad Market Index - GURU.Markets
HeartBeam develops personal heart monitoring technology that allows patients to perform diagnostic ECGs at home. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the medtech sector.
Change in the price of a company, segment, and market as a whole per day
BEAT - Daily change in the company's share price HeartBeam Inc.
HeartBeam, Inc.'s daily price change reflects volatility in the medical technology sector. The indicator demonstrates sensitivity to news about the development and approval of its remote cardiac monitoring device, serving as a valuable element for analysis.
Daily change in the price of a set of shares in a market segment - Heart
HeartBeam, Inc. is a medical technology company. This chart shows high volatility. A comparison with BEAT, a company with remote cardiac monitoring technology, helps to assess it as a high-risk tech stock.
Daily change in the price of a broad market stock, index - GURU.Markets
HeartBeam develops technology for remote diagnostics of cardiac diseases. This innovative medical technology company's shares are responding to clinical advances and regulatory decisions. Its history reflects the medical technology sector's contribution to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization HeartBeam Inc.
HeartBeam, Inc.'s year-over-year performance is the story of its development of a system for remotely diagnosing heart attacks. Its market capitalization over the next 12 months depends entirely on progress toward FDA approval. The success of its technology, which creates a 3D vectorcardiogram using a simple device, could become a breakthrough in cardiology.
Annual dynamics of market capitalization of the market segment - Heart
HeartBeam, Inc. develops innovative technology for remote diagnosis of heart disease. Its stock price is extremely volatile, reflecting investor confidence in its breakthrough potential and ability to commercialize its unique technology, rather than current financial results.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
HeartBeam is a very small and highly speculative medical technology company. Its stock price has nothing to do with fundamentals or the economy, but is driven by news of trials and investor confidence in the potential of its developments, making it a high-risk bet.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization HeartBeam Inc.
HeartBeam is developing technology for remote diagnostics of heart disease. Being in the development stage, its monthly valuation is based on expectations. News about progress toward FDA approval and clinical trial data are the primary drivers of its pricing.
Monthly dynamics of market capitalization of the market segment - Heart
HeartBeam is developing remote cardiac monitoring technology that allows patients to record ECGs and send the data to their doctors using a portable device. The graph below shows the overall dynamics in the cardiac equipment sector, where telemedicine is opening up new opportunities.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
HeartBeam, Inc. develops technology for remote cardiac monitoring. It is an early-stage medical startup. Its shares are driven by news of regulatory approvals and clinical trial results, rather than by general market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization HeartBeam Inc.
Short-term price movements for HeartBeam, which is developing technology for remote heart attack diagnosis, are speculative. Any news regarding the progress of FDA approval or clinical trials could cause sharp price movements.
Weekly dynamics of market capitalization of the market segment - Heart
HeartBeam and the entire innovative medical device sector are moving on a backdrop of news about clinical trials and regulatory approvals. These factors create high volatility for everyone. The chart will show how the company fares in this risky field.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
HeartBeam and the entire innovative medical device sector are moving on a backdrop of news about clinical trials and regulatory approvals. These factors create high volatility for everyone. The chart will show how the company fares in this risky field.
Market capitalization of the company, segment and market as a whole
BEAT - Market capitalization of the company HeartBeam Inc.
HeartBeam's market cap is the financial valuation of a company developing a portable device for diagnosing heart attacks using 3D ECG technology. The chart reflects investor hopes for its innovative approach. Its speculative dynamics tell the story of how the market weighs a huge potential market against the long road to FDA approval and commercialization.
BEAT - Share of the company's market capitalization HeartBeam Inc. within the market segment - Heart
HeartBeam develops remote cardiac monitoring technology that allows patients to perform diagnostic ECGs at home and send them to their doctors. Its market share reflects the potential of its devices for telemedicine. The chart below shows the market share of this technology for heart health.
Market capitalization of the market segment - Heart
HeartBeam is developing technology for remote diagnosis of heart attacks. The chart below shows the overall market capitalization of the entire sector. Its growth reflects the need for faster and more accurate diagnosis. HeartBeam's technology could become a vital tool for saving lives.
Market capitalization of all companies included in a broad market index - GURU.Markets
Heart disease diagnostics, as seen in the graph, are exploring new methods. HeartBeam is developing technology to create a 3D model of the heart based on a standard ECG. Its capitalization is a risky bet that its technology will improve the early detection of heart attacks.
Book value capitalization of the company, segment and market as a whole
BEAT - Book value capitalization of the company HeartBeam Inc.
HeartBeam's book value is the material basis for the creation of the cardiac monitoring system. The chart reflects investments in the development and patenting of its technology, which allows for the creation of a 3D model of the heart based on ECG data collected with a portable device.
BEAT - Share of the company's book capitalization HeartBeam Inc. within the market segment - Heart
HeartBeam develops medical devices for remote cardiac monitoring. Its share of the sector's assets is its R&D capacity. Currently, the company is building the intellectual and engineering foundation to commercialize its innovative vectorcardiography technology.
Market segment balance sheet capitalization - Heart
HeartBeam, Inc. develops cardiac diagnostic devices. Its model is asset-light, focusing on software and algorithm development while hardware production can be outsourced. In the capital-intensive medical technology sector, this exemplifies a focus on intellectual property.
Book value of all companies included in the broad market index - GURU.Markets
HeartBeam's assets are not pacemakers, but rather a unique technology that allows patients to independently record hospital-quality ECGs using a simple device and a smartphone. The company's balance sheet reflects the value of this development. The chart shows the capital invested in revolutionizing cardiac monitoring.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - HeartBeam Inc.
HeartBeam develops technology for remote diagnosis of heart disease. Its market capitalization reflects its potential to transform the way patients at risk of heart attack are monitored. Investors are paying for this innovative medical technology.
Market to book capitalization ratio in a market segment - Heart
HeartBeam develops technology for remote cardiac monitoring. Its value lies in its patents and potential to transform cardiac diagnostics. This chart shows the premium investors are paying for its breakthrough technology, which has the potential to save lives, rather than its tangible assets.
Market to book capitalization ratio for the market as a whole
HeartBeam develops technology for remote cardiac monitoring. The company's value lies in its unique technology and patents. This chart demonstrates the high premium the market is willing to pay for cutting-edge solutions at the intersection of medicine and technology, despite the modest book value of its tangible assets.
Debts of the company, segment and market as a whole
BEAT - Company debts HeartBeam Inc.
HeartBeam is developing technology for remote diagnostics of heart disease. Commercializing a new medical device is a lengthy and expensive process, requiring clinical trials and regulatory approval. Debt financing can help the company navigate these steps.
Market segment debts - Heart
HeartBeam, Inc. develops medical devices for remote cardiac monitoring. Commercialization of medical devices requires investment in R&D, regulatory approvals, and marketing. This chart shows how the company finances this long and capital-intensive process, typically through equity financing in the early stages.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio HeartBeam Inc.
HeartBeam is developing technology for remote diagnosis of heart disease. This chart shows how the company is funding its path to commercialization. For a medical technology startup, high debt is a huge risk. Success depends on gaining regulatory approval and convincing doctors to use their new technology.
Market segment debt to market segment book capitalization - Heart
HeartBeam is developing remote cardiac monitoring technology that allows high-risk patients to quickly and accurately record ECGs and send them to their doctors. This chart compares the company's debt required to commercialize this technology to the total market capitalization of the entire cardiology sector. It illustrates the financial implications of implementing innovations in cardiology.
Debt to book value of all companies in the market
HeartBeam develops technology for remote cardiac monitoring. Bringing a new medical device to market is a lengthy and expensive process, requiring regulatory approval. The chart shows how the company finances its development. Its debt load, compared to the MedTech sector, reflects its stage of development and financial risks.
P/E of the company, segment and market as a whole
P/E - HeartBeam Inc.
This chart for HeartBeam, a company developing remote cardiac monitoring technology, assesses its potential in telemedicine. The high price per dollar of future revenue reflects investors' belief in their device's potential to save lives. The volatility reflects progress in securing approvals and securing partnerships with clinics.
P/E of the market segment - Heart
This chart shows the average valuation for the medical technology sector—a benchmark for HeartBeam. The high valuation across the industry reflects confidence in the future of telemedicine. Comparison with this metric helps understand whether investors consider the company's remote cardiac monitoring technology to be among the most promising in the field.
P/E of the market as a whole
HeartBeam is developing remote cardiac monitoring technology that allows patients to record hospital-quality ECGs using a portable device and a smartphone. This chart reflects sentiment in the medical technology sector. It helps understand how the market views this technology's potential for improving cardiac diagnosis and its potential for clinical adoption.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company HeartBeam Inc.
HeartBeam is developing technology for remote cardiac diagnostics, enabling 12-lead ECG recordings using a portable device. The company's future profitability depends on the commercialization of this technology. This chart shows whether analysts believe the HeartBeam device will be adopted by doctors and patients.
%20P%2FE%20HeartBeam%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-HeartBeam-Inc.&v=1772670554152 "Chart of the company's future (projected) P/E HeartBeam Inc.")
Future (projected) P/E of the market segment - Heart
HeartBeam is developing technology to improve heart attack diagnosis using a portable device that allows for 12-lead ECGs at home. This chart compares its future profitability expectations with those of the medical technology sector, demonstrating whether the market believes it can change the standards of cardiac diagnostics.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Heart&v=1772670554184 "Future (projected) P/E graph of the market segment - Heart")
Future (projected) P/E of the market as a whole
HeartBeam is developing technology for remote cardiac monitoring. This chart reflects the overall sentiment in the healthcare sector. For BEAT, the focus isn't so much on economics as on gaining regulatory approval and demonstrating that their technology improves diagnostics. It's a growth story driven by innovation.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772670554244 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit HeartBeam Inc.
HeartBeam is developing a medical device based on vectorcardiography (VCG) technology for remote cardiac monitoring. This chart shows the company's financial progress as it seeks to commercialize its new technology to improve heart attack diagnosis. The results reflect investments in research and clinical trials.
Profit of companies in the market segment - Heart
HeartBeam is developing a medical device based on vectorcardiography (VCG) technology for remote monitoring and diagnosis of heart attacks. The device provides high-quality 12-lead ECG data. This graph shows the overall profitability of the cardiac equipment sector, demonstrating the demand for technologies that make diagnostics more accessible.
Overall market profit
HeartBeam is developing a medical device for remote cardiac monitoring. Demand for such technologies is fueled by the trend toward telemedicine. The introduction of new medical devices is a long process that depends less on short-term economic cycles than on clinical effectiveness and regulatory approval.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company HeartBeam Inc.
HeartBeam is developing technology for more accurate and rapid heart attack diagnosis using a standard ECG. The company's future depends on the approval and acceptance of its technology by physicians. This chart shows how analysts assess the commercial potential of this innovative diagnostic approach.
%20profit%20of%20the%20company%20HeartBeam%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-HeartBeam-Inc.&v=1772670554576 "Graph of future (projected) profit of the company HeartBeam Inc.")
Future (predicted) profit of companies in the market segment - Heart
HeartBeam is developing technology to more accurately and quickly diagnose heart attacks using a standard ECG. This chart shows forecasts for the medical technology sector. HeartBeam's future profitability depends on FDA approval and the medical community's belief that its technology can improve diagnostics and save patients' lives.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Heart&v=1772670554657 "Graph of future (predicted) profits of companies in a market segment - Heart")
Future (predicted) profit of the market as a whole
HeartBeam, Inc. develops technology for remote cardiac monitoring. The introduction of new medical devices depends on regulatory approval and the healthcare system's willingness to pay for them. This graph, which displays profit forecasts, is an indicator of the overall economic health, which impacts healthcare budgets and innovation.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772670554664 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - HeartBeam Inc.
HeartBeam develops remote cardiac monitoring technology that enables hospital-grade diagnostic data to be obtained using a portable device. This chart reflects investors' confidence in the technology. The valuation is based on the potential to transform approaches to cardiac diagnosis, not on current sales.
P/S market segment - Heart
HeartBeam develops remote cardiac monitoring technology that allows patients to record diagnostic-quality ECGs using a portable device and a smartphone. This chart shows the average rating for medical device manufacturers, helping to understand how the market perceives the potential of HeartBeam's technology to improve cardiac diagnostics.
P/S of the market as a whole
HeartBeam develops remote cardiac monitoring technology that allows patients to perform their own diagnostic ECG and send it to their doctor. This average market valuation indicator shows how highly investors value companies that use technology to make healthcare more accessible and proactive.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company HeartBeam Inc.
HeartBeam is developing a medical device based on ECG technology for remote monitoring of cardiac conditions. This chart reflects investors' confidence in the commercial potential of this technology. The valuation is based on expected future revenues from sales of the device, which could aid in the early detection of heart attacks.
%20P%2FS%20HeartBeam%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-HeartBeam-Inc.&v=1772670554794 "The graph of the company's future (projected) P/S HeartBeam Inc.")
Future (projected) P/S of the market segment - Heart
HeartBeam is developing technology for more accurate and rapid heart attack diagnosis using ECGs. This chart compares the company's future revenue expectations with its industry. It reflects investors' belief that its technology can improve the standards of cardiac diagnostics.
%20P%2FS%20market%20segment%20graph%20-%20Heart&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Heart&v=1772670554839 "Future (projected) P/S market segment graph - Heart")
Future (projected) P/S of the market as a whole
HeartBeam is developing a medical device for remote cardiac monitoring, allowing patients to perform 12-lead ECGs at home. The optimism expressed by this indicator is fueled by innovations in telemedicine. HeartBeam's technology has the potential to radically change approaches to cardiac diagnosis and is an indicator of the development of digital healthcare.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772670554910 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales HeartBeam Inc.
HeartBeam is developing a medical device for remote cardiac monitoring. While the company is in the development and regulatory approval phase, it has no commercial sales yet. Revenue, if any, is likely derived from research grants or contracts.
Sales of companies in the market segment - Heart
HeartBeam is developing remote cardiac monitoring technology that allows patients to record diagnostic-quality ECGs using a portable device. This graph illustrates the growth of the digital healthcare market, where telemedicine and remote diagnostics like HeartBeam's are becoming the new standard of care.
Overall market sales
HeartBeam, Inc. develops technology for remote cardiac monitoring. The adoption of its devices depends on the healthcare system's willingness to embrace innovation. The increase in overall economic revenue, reflected in this graph, improves the financial health of clinics and insurance companies. This accelerates the adoption of new technologies that can improve diagnostics and save lives.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company HeartBeam Inc.
HeartBeam, Inc. is developing remote cardiac monitoring technology that allows patients to record diagnostic-quality ECGs using a portable device and a smartphone. This chart shows analysts' expectations for the commercialization of this technology in telemedicine and cardiology.
%20sales%20of%20the%20company%20HeartBeam%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-HeartBeam-Inc.&v=1772670555045 "Schedule of future (projected) sales of the company HeartBeam Inc.")
Future (projected) sales of companies in the market segment - Heart
HeartBeam is developing technology for remote monitoring and diagnosis of heart disease using a 12-lead ECG, accessible to patients at any time. This chart shows forecasts for the cardiology sector. It illustrates the trend toward telemedicine and the expansion of patient control over their health.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Heart&v=1772670555050 "Schedule of future (projected) sales of companies in the market segment - Heart")
Future (projected) sales of the market as a whole
HeartBeam, a company developing remote cardiac monitoring devices, sees this chart as an indicator of telemedicine adoption. The economic growth reflected here allows the healthcare system to invest in technologies that make medical care more accessible and convenient for patients with chronic conditions.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772670555105 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality HeartBeam Inc.
HeartBeam is developing a personal heart monitoring device aimed at more accurate and rapid heart attack diagnosis. While in the development and regulatory approval phase, the company is incurring significant costs. This chart shows the investment it is making in its technology to make it profitable in the future.
Market segment marginality - Heart
HeartBeam is developing a medical device for remote cardiac monitoring that provides diagnostic-quality ECGs. For a medtech company at the commercialization stage, efficiency means the ability to establish production and convince the medical community of the technology's value. The chart reflects their operating costs along the way.
Market marginality as a whole
HeartBeam is developing remote cardiac monitoring technology that allows patients to have diagnostic ECGs performed at any time. Based on overall profitability data, HeartBeam is working in the digital health space. Their profitability will depend on the approval and adoption of their device for improving cardiac diagnostics.
Employees in the company, segment and market as a whole
Number of employees in the company HeartBeam Inc.
HeartBeam is developing technology for remote cardiac monitoring. This graph shows its team of engineers and clinicians. The size of its staff is an indicator of its progress in developing and obtaining regulatory approval for its innovative ECG system.
Share of the company's employees HeartBeam Inc. within the market segment - Heart
HeartBeam is developing technology to more accurately diagnose heart attacks using a standard ECG. This graph shows the percentage of medical engineers and clinicians in the cardiac diagnostics niche that HeartBeam attracts. It reflects its potential to change the standard of chest pain care with its innovative software.
Number of employees in the market segment - Heart
HeartBeam is developing remote cardiac monitoring technology that enables 12-lead ECG diagnostics using a portable device. Its staff consists of engineers and clinicians. This timeline shows the company's preparations for market entry. The team's growth will be driven by regulatory approval and commercialization.
Number of employees in the market as a whole
HeartBeam develops technology for remote diagnostics of heart disease. The digital health sector is one of the fastest-growing. This chart shows the overall picture, but for HeartBeam, the key driver is the need for more effective and accessible cardiac monitoring.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company HeartBeam Inc. (BEAT)
HeartBeam develops AI-based medical devices. It's a tech company whose main assets are software and patents. This graph should show a high return on investment per employee, as its product is easily scalable. This is the value of intellectual capital.
%20of%20the%20company%20HeartBeam%20Inc.%20(BEAT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-HeartBeam-Inc.-BEAT&v=1772670555301 "Chart of market capitalization per employee (in thousands of dollars) of the company HeartBeam Inc. (BEAT)")
Market capitalization per employee (in thousands of dollars) in the market segment - Heart
HeartBeam, Inc. is developing technology for remote heart attack diagnosis based on standard ECGs. For a medical technology company, this metric reflects the potential of its device to save lives and carve out a niche in the market. The chart shows how much investors see in this innovation, based on the development team.
%20by%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Heart&v=1772670555325 "Market capitalization per employee (in thousands of dollars) by market segment - Heart")
Market capitalization per employee (in thousands of dollars) for the overall market
HeartBeam is developing remote cardiac monitoring technology that allows patients to record diagnostic-quality ECGs using a portable device. The company is a digital healthcare company. The chart shows how the market perceives the potential of this technology, which could improve cardiac diagnosis and save lives.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772670555360 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company HeartBeam Inc. (BEAT)
HeartBeam (BEAT) is a medical diagnostics company developing a vest technology for more accurate and rapid heart attack diagnosis (EKG). It's an R&D company. This chart shows the R&D capital burn per engineer to commercialize this innovative diagnostic system.
%20Chart%20HeartBeam%20Inc.%20(BEAT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-HeartBeam-Inc.-BEAT&v=1772670555390 "Company Profit Per Employee (in thousands of dollars) Chart HeartBeam Inc. (BEAT)")
Profit per employee (in thousands of dollars) in the market segment - Heart
HeartBeam (BEAT) is a medical technology company developing a personal ECG monitoring system that enables remote diagnosis of heart attacks. It's an R&D-intensive business. This chart shows how effectively the team of engineers and doctors is advancing their innovative diagnostic technology toward commercialization.
%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Heart&v=1772670555434 "Chart of profit per employee (in thousands of dollars) in the market segment - Heart")
Profit per employee (in thousands of dollars) for the market as a whole
HeartBeam is developing a medical device (patch and software) for remote cardiac monitoring. It's a MedTech with SaaS elements. This chart shows the company is in the R&D and regulatory approvals phase. Revenue per employee (engineer, physician) is negative. Success will mean high scalability: subscriptions to the monitoring service will generate recurring revenue.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772670555481 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee HeartBeam Inc. (BEAT)
HeartBeam is developing technology for remote cardiac monitoring. For a medical technology company in the development stage, this graph is a glimpse into the future. Revenue per employee will increase after the approval and commercialization of their device, demonstrating its popularity among doctors and patients.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-HeartBeam-Inc.-BEAT&v=1772670555493 "Sales chart per company employee HeartBeam Inc. (BEAT)")
Sales per employee in the market segment - Heart
HeartBeam is developing a wearable device (patch) and a platform for 3D ECG monitoring to aid in the early diagnosis of heart attacks. They are a MedTech company. This chart shows the average revenue per employee in the sector. It serves as a benchmark, demonstrating the level of productivity required from their innovative technology to enter the cardiac diagnostics market.
Sales per employee for the market as a whole
HeartBeam, Inc. (BEAT) develops medical technology (patches and software) for remote monitoring of cardiac patients, enabling hospital-quality ECGs at home. This is R&D. This chart shows how the company is preparing for commercialization of its technology and its revenue per employee.
Short shares by company, segment and market as a whole
Shares shorted by company HeartBeam Inc. (BEAT)
HeartBeam is developing a wearable 3D cardiac monitoring device (patch) to aid in the diagnosis of heart attacks. The medical device market is competitive. The chart shows the number of "bears" betting that the company's technology will not receive FDA approval or that it will fail to prove its superiority over existing ECG devices, such as the Apple Watch.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-HeartBeam-Inc.-BEAT&v=1772670555612 "Short Shares Chart for the Company HeartBeam Inc. (BEAT)")
Shares shorted by market segment - Heart
HeartBeam develops portable ECG devices that allow heart patients to monitor their condition from home. This chart measures bearish sentiment in the sector. It rises when investors doubt that new digital health gadgets will be widely adopted or reimbursed by insurers.
Shares shorted by the overall market
HeartBeam develops technology for remote diagnosis of heart disease. It's a highly competitive medtech market. This chart reflects the general fear. When investors are pessimistic, they are extremely skeptical of new medtech devices that require expensive testing and a complex FDA approval process. BEAT shares are selling off due to the high risk and long road to market.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator HeartBeam Inc. (BEAT)
HeartBeam, Inc. develops ECG technology for remote cardiac monitoring aimed at the early detection of heart attacks. This chart tracks speculative interest in their medical technology. It shows when patent or trial news is "overheating" the stock (above 70) or when the stock is "oversold" (below 30) pending FDA approval.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-HeartBeam-Inc.-BEAT&v=1772670555725 "RSI 14 indicator chart for the company's stock HeartBeam Inc. (BEAT)")
RSI 14 Market Segment - Heart
HeartBeam (BEAT) — an "EKG" in your pocket. Their "thing" is a wearable (like a credit card) device that takes a full (12-lead) ECG at any time. The "Heart" (medtech) sector thrives on R&D. RSI\_14\_Seg shows whether the *entire* sector is "overbought." This helps differentiate: is BEAT's growth their "niche" or a general "overheating"?
RSI 14 for the overall market
HeartBeam (BEAT) is a biotech company. Like everything in its sector, it's critically dependent on this chart. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BEAT (HeartBeam Inc.)
HeartBeam is a cardiac technology company developing portable devices (patches) for 12-lead ECG and out-of-hospital cardiac monitoring. This chart shows the analysts' average 12-month forecast. It represents their collective speculative bet on whether this technology will receive FDA approval and physician acceptance.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BEAT-HeartBeam-Inc.&v=1772670555759 "A chart showing analyst consensus forecasts for the expected stock price. BEAT (HeartBeam Inc.)")
The difference between the consensus estimate and the actual stock price BEAT (HeartBeam Inc.)
HeartBeam is a medical technology company developing a portable device (the size of a credit card) for performing 12-lead ECGs at home for patients at risk of heart attack. This chart shows the difference between the market valuation and the consensus forecast. It reveals whether experts believe this telemedicine technology will be adopted.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BEAT-HeartBeam-Inc.&v=1772670555767 "A chart showing the difference between the consensus forecast and the actual stock price. BEAT (HeartBeam Inc.)")
Analyst consensus forecast for stock prices by market segment - Heart
HeartBeam is developing an "EKG in a wallet"—a credit card-sized device designed to help patients (and their doctors) detect signs of a heart attack early. This chart shows analysts' overall expectations for the cardiac device sector, reflecting whether experts believe the wearable diagnostics market will grow.
Analysts' consensus forecast for the overall market share price
HeartBeam is a medical company developing a portable ECG device for remote cardiac monitoring, which helps doctors diagnose heart attacks faster. This chart shows the overall risk appetite. For HeartBeam, a company with innovative but not yet commercialized technology, overall market optimism is important for funding and bringing the product to market.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index HeartBeam Inc.
HeartBeam is a MedTech company working on ECGs on the move. They are developing wearable devices (a patch and a credit card) that allow patients at risk of heart attack to record a 3D ECG during an attack and send it to their doctor. This graph is a clear indicator of their R&D efforts, reflecting their progress toward FDA approval and their chances of commercializing this innovative technology.
AKIMA Market Segment Index - Heart
HeartBeam (BEAT) is a medical technology company developing a portable smartphone-based 3D ECG system for remote monitoring of heart patients. The chart shows the segment average, helping investors assess how this innovative remote diagnostic technology compares to the average in the cardiac equipment sector.
The AKIM Index for the overall market
HeartBeam is a medtech company that has developed a personal device (the size of a credit card) for detecting heart attacks. This chart, which reflects the market average, is a backdrop. It helps assess how this tech company, which is seeking FDA approval, fits into the context of overall macroeconomic trends.
